News
Neal Richardson's departure from SLDC comes with a substantial payout, but the terms of the deal go beyond just money.
Tang Capital makes bid for 4th Bay Area biotech in 3 months, offering to take out Cargo Therapeutics
Kevin Tang's Concentra Biosciences lines up deal for flailing cancer cell therapy company Cargo Therapeutics — potentially its fourth buyout of a Bay Area biotech this year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results